{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:49:16Z","timestamp":1761824956700,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Medical Sciences"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.advms.2023.06.002","type":"journal-article","created":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T14:27:42Z","timestamp":1688653662000},"page":"238-248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Phenotypic and functional characterization of subpopulation of Imatinib resistant chronic myeloid leukemia cell line"],"prefix":"10.1016","volume":"68","author":[{"given":"Yalda","family":"Hekmatshoar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aynur","family":"Karadag Gurel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tulin","family":"Ozkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3295-404X","authenticated-orcid":false,"given":"Yalda","family":"Rahbar Saadat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4679-9079","authenticated-orcid":false,"given":"Asli","family":"Koc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2482-0359","authenticated-orcid":false,"given":"Arzu Zeynep","family":"Karabay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sureyya","family":"Bozkurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asuman","family":"Sunguroglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.advms.2023.06.002_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0092-8674(84)90077-1","article-title":"Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22","volume":"36","author":"Groffen","year":"1984","journal-title":"Cell"},{"key":"10.1016\/j.advms.2023.06.002_bib2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3389\/fonc.2019.00603","article-title":"Tyrosine kinase inhibitors available for chronic myeloid leukemia: efficacy and safety","volume":"9","author":"Garcia-Gutierrez","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.advms.2023.06.002_bib3","first-page":"207","article-title":"Imatinib triggers mesenchymal-like conversion of CML cells associated with increased aggressiveness","volume":"4","author":"Puissant","year":"2012","journal-title":"J\u00a0Mol Cell Biol"},{"key":"10.1016\/j.advms.2023.06.002_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13194820","article-title":"Resistance to tyrosine kinase inhibitors in chronic myeloid leukemia-from molecular mechanisms to clinical relevance","volume":"13","author":"Alves","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.advms.2023.06.002_bib5","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.hoc.2011.09.004","article-title":"Chronic myeloid leukemia: mechanisms of resistance and treatment","volume":"25","author":"Jabbour","year":"2011","journal-title":"Hematol Oncol Clin N Am"},{"key":"10.1016\/j.advms.2023.06.002_bib6","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1080\/10245332.2018.1488795","article-title":"Expression analysis of Akirin-2, NFkappaB-p65 and beta-catenin proteins in imatinib resistance of chronic myeloid leukemia","volume":"23","author":"Karabay","year":"2018","journal-title":"Hematology"},{"key":"10.1016\/j.advms.2023.06.002_bib7","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification","volume":"293","author":"Gorre","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.advms.2023.06.002_bib8","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1042\/BCJ20170712","article-title":"The role of metabolism and tunneling nanotube-mediated intercellular mitochondria exchange in cancer drug resistance","volume":"475","author":"Hekmatshoar","year":"2018","journal-title":"Biochem J"},{"key":"10.1016\/j.advms.2023.06.002_bib9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.blre.2005.08.003","article-title":"Tumor microenvironment and drug resistance in hematologic malignancies","volume":"20","author":"Li","year":"2006","journal-title":"Blood Rev"},{"key":"10.1016\/j.advms.2023.06.002_bib10","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.1158\/0008-5472.CAN-14-1174","article-title":"Phenotype switching: tumor cell plasticity as a resistance mechanism and target for therapy","volume":"74","author":"Kemper","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.advms.2023.06.002_bib11","first-page":"75","article-title":"Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic","volume":"1796","author":"Voulgari","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.advms.2023.06.002_bib12","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrc822","article-title":"Epithelial-mesenchymal transitions in tumour progression","volume":"2","author":"Thiery","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.advms.2023.06.002_bib13","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.advms.2023.06.002_bib14","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1038\/onc.2010.215","article-title":"EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer","volume":"29","author":"Singh","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.advms.2023.06.002_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40169-014-0035-0","article-title":"Novel clinical therapeutics targeting the epithelial to mesenchymal transition","volume":"3","author":"Kothari","year":"2014","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.advms.2023.06.002_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12929-018-0440-6","article-title":"Emerging roles of epithelial-mesenchymal transition in hematological malignancies","volume":"25","author":"Chen","year":"2018","journal-title":"J\u00a0Biomed Sci"},{"key":"10.1016\/j.advms.2023.06.002_bib17","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1007\/s00018-010-0338-2","article-title":"Molecular signaling of the epithelial to mesenchymal transition in generating and maintaining cancer stem cells","volume":"67","author":"Ouyang","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.advms.2023.06.002_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.14715\/cmb\/2018.64.6.5","article-title":"Characterization of imatinib-resistant K562 cell line displaying resistance mechanisms","volume":"64","author":"Hekmatshoar","year":"2018","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"10.1016\/j.advms.2023.06.002_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229104","article-title":"Adaptive phenotypic modulations lead to therapy resistance in chronic myeloid leukemia cells","volume":"15","author":"Baykal-Kose","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.advms.2023.06.002_bib20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nat Protoc"},{"key":"10.1016\/j.advms.2023.06.002_bib21","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2775433","article-title":"Circular RNA hsa_circ_0002360 promotes proliferation and invasion and inhibits oxidative stress in gastric cancer by sponging miR-629-3p and regulating the PDLIM4 expression","volume":"2022","author":"Yu","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.advms.2023.06.002_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/nar\/27.1.29","article-title":"KEGG: Kyoto Encyclopedia of genes and genomes","volume":"27","author":"Ogata","year":"1999","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.advms.2023.06.002_bib23","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jiph.2022.03.004","article-title":"Bioinformatics analysis of potential therapeutic targets for COVID-19 infection in patients with carotid atherosclerosis","volume":"15","author":"Yanchao","year":"2022","journal-title":"J\u00a0Infect Public Health"},{"key":"10.1016\/j.advms.2023.06.002_bib24","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3389\/fgene.2020.00734","article-title":"Analysis of differentially expressed genes and molecular pathways in familial hypercholesterolemia involved in atherosclerosis: a systematic and bioinformatics approach","volume":"11","author":"Udhaya Kumar","year":"2020","journal-title":"Front Genet"},{"key":"10.1016\/j.advms.2023.06.002_bib25","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3324\/haematol.2014.113852","article-title":"A\u00a0hostel for the hostile: the bone marrow niche in hematologic neoplasms","volume":"100","author":"Krause","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.advms.2023.06.002_bib26","doi-asserted-by":"crossref","first-page":"7827","DOI":"10.1038\/s41598-019-43924-x","article-title":"FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics","volume":"9","author":"Li","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.advms.2023.06.002_bib27","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1172\/JCI118820","article-title":"Bcr\/Abl expression stimulates integrin function in hematopoietic cell lines","volume":"98","author":"Bazzoni","year":"1996","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.advms.2023.06.002_bib28","doi-asserted-by":"crossref","DOI":"10.3892\/or.2022.8355","article-title":"Genomewide expression and methylation analyses reveal aberrant cell adhesion signaling in tyrosine kinase inhibitorresistant CML cells","volume":"48","author":"Kaehler","year":"2022","journal-title":"Oncol Rep"},{"key":"10.1016\/j.advms.2023.06.002_bib29","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0022-2143(97)90192-X","article-title":"Pathophysiology of CML: do defects in integrin function contribute to the premature circulation and massive expansion of the BCR\/ABL positive clone?","volume":"129","author":"Verfaillie","year":"1997","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.advms.2023.06.002_bib30","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1093\/hmg\/ddu106","article-title":"Combined protein- and nucleic acid-level effects of rs1143679 (R77H), a lupus-predisposing variant within ITGAM","volume":"23","author":"Maiti","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.advms.2023.06.002_bib31","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1126\/science.1201219","article-title":"Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment","volume":"333","author":"Notta","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.advms.2023.06.002_bib32","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1182\/blood.2019001417","article-title":"Integrin alpha6 mediates the drug resistance of acute lymphoblastic B-cell leukemia","volume":"136","author":"Gang","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.advms.2023.06.002_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030706","article-title":"The increased expression of integrin alpha6 (ITGA6) enhances drug resistance in EVI1(high) leukemia","volume":"7","author":"Yamakawa","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.advms.2023.06.002_bib34","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1186\/s12885-022-10099-0","article-title":"Identification of TLN1 as a prognostic biomarker to effect cell proliferation and differentiation in acute myeloid leukemia","volume":"22","author":"Cui","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.advms.2023.06.002_bib35","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1158\/1078-0432.CCR-13-0082","article-title":"A\u00a0targeted RNAi screen of the breast cancer genome identifies KIF14 and TLN1 as genes that modulate docetaxel chemosensitivity in triple-negative breast cancer","volume":"19","author":"Singel","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.advms.2023.06.002_bib36","doi-asserted-by":"crossref","first-page":"27239","DOI":"10.18632\/oncotarget.4835","article-title":"Talin1 targeting potentiates anti-angiogenic therapy by attenuating invasion and stem-like features of glioblastoma multiforme","volume":"6","author":"Kang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.advms.2023.06.002_bib37","first-page":"4409","article-title":"Increased expression of integrin-linked kinase is correlated with melanoma progression and poor patient survival","volume":"9","author":"Dai","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.advms.2023.06.002_bib38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc1524","article-title":"Integrin-linked kinase: a cancer therapeutic target unique among its ILK","volume":"5","author":"Hannigan","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.advms.2023.06.002_bib39","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.stem.2020.04.005","article-title":"Integrin-linked kinase mediates therapeutic resistance of quiescent CML stem cells to tyrosine kinase inhibitors","volume":"27","author":"Rothe","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.advms.2023.06.002_bib40","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/s41375-020-0866-1","article-title":"Specific, targetable interactions with the microenvironment influence imatinib-resistant chronic myeloid leukemia","volume":"34","author":"Kumar","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.advms.2023.06.002_bib41","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","article-title":"EMT, CSCs, and drug resistance: the mechanistic link and clinical implications","volume":"14","author":"Shibue","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.advms.2023.06.002_bib42","doi-asserted-by":"crossref","first-page":"E82","DOI":"10.21037\/jtd.2019.06.11","article-title":"Epithelial-to-mesenchymal transition and drug resistance: transitioning away from death","volume":"11","author":"Song","year":"2019","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.advms.2023.06.002_bib43","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1878-0261.12085","article-title":"EMT- and MET-related processes in nonepithelial tumors: importance for disease progression, prognosis, and therapeutic opportunities","volume":"11","author":"Kahlert","year":"2017","journal-title":"Mol Oncol"},{"key":"10.1016\/j.advms.2023.06.002_bib44","first-page":"235","article-title":"CD44, hyaluronan, the hematopoietic stem cell, and leukemia-initiating cells","volume":"6","author":"Zoller","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.advms.2023.06.002_bib45","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1007\/s00018-011-0772-9","article-title":"Lessons from common markers of tumor-initiating cells in solid cancers","volume":"68","author":"Gires","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.advms.2023.06.002_bib46","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/1476-4598-9-288","article-title":"Increasing CD44+\/CD24(-) tumor stem cells, and upregulation of COX-2 and HDAC6, as major functions of HER2 in breast tumorigenesis","volume":"9","author":"Wang","year":"2010","journal-title":"Mol Cancer"},{"key":"10.1016\/j.advms.2023.06.002_bib47","doi-asserted-by":"crossref","first-page":"10158","DOI":"10.1073\/pnas.0703478104","article-title":"Phenotypic characterization of human colorectal cancer stem cells","volume":"104","author":"Dalerba","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.advms.2023.06.002_bib48","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.scr.2016.02.028","article-title":"CD44(high)CD24(low) molecular signature determines the cancer stem cell and EMT phenotype in oral squamous cell carcinoma","volume":"16","author":"Ghuwalewala","year":"2016","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.advms.2023.06.002_bib49","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The epithelial-mesenchymal transition generates cells with properties of stem cells","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"}],"container-title":["Advances in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112623000214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112623000214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:45:07Z","timestamp":1761824707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1896112623000214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1896112623000214"],"URL":"https:\/\/doi.org\/10.1016\/j.advms.2023.06.002","relation":{},"ISSN":["1896-1126"],"issn-type":[{"type":"print","value":"1896-1126"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotypic and functional characterization of subpopulation of Imatinib resistant chronic myeloid leukemia cell line","name":"articletitle","label":"Article Title"},{"value":"Advances in Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.advms.2023.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Medical University of Bialystok. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}